175 related articles for article (PubMed ID: 11682398)
1. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment.
De Wolf AM; Fragen RJ; Avram MJ; Fitzgerald PC; Rahimi-Danesh F
Anesth Analg; 2001 Nov; 93(5):1205-9. PubMed ID: 11682398
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret.
Venn RM; Karol MD; Grounds RM
Br J Anaesth; 2002 May; 88(5):669-75. PubMed ID: 12067004
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine.
Bhana N; Goa KL; McClellan KJ
Drugs; 2000 Feb; 59(2):263-8; discussion 269-70. PubMed ID: 10730549
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and sedative effects of dexmedetomidine in dairy calves.
Cagnardi P; Villa R; Ravasio G; Lucatello L; Di Cesare F; Capolongo F; Boccardo A; Pravettoni D
N Z Vet J; 2017 Jan; 65(1):14-18. PubMed ID: 27643584
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
[TBL] [Abstract][Full Text] [Related]
6. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions.
Hall JE; Uhrich TD; Barney JA; Arain SR; Ebert TJ
Anesth Analg; 2000 Mar; 90(3):699-705. PubMed ID: 10702460
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine.
Scheinin H; Karhuvaara S; Olkkola KT; Kallio A; Anttila M; Vuorilehto L; Scheinin M
Clin Pharmacol Ther; 1992 Nov; 52(5):537-46. PubMed ID: 1358496
[TBL] [Abstract][Full Text] [Related]
8. A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children.
Petroz GC; Sikich N; James M; van Dyk H; Shafer SL; Schily M; Lerman J
Anesthesiology; 2006 Dec; 105(6):1098-110. PubMed ID: 17122572
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
Lee S; Kim BH; Lim K; Stalker D; Wisemandle W; Shin SG; Jang IJ; Yu KS
J Clin Pharm Ther; 2012 Dec; 37(6):698-703. PubMed ID: 22650799
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of dexmedetomidine after intranasal administration.
Iirola T; Vilo S; Manner T; Aantaa R; Lahtinen M; Scheinin M; Olkkola KT
Eur J Clin Pharmacol; 2011 Aug; 67(8):825-31. PubMed ID: 21318594
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age.
Vilo S; Rautiainen P; Kaisti K; Aantaa R; Scheinin M; Manner T; Olkkola KT
Br J Anaesth; 2008 May; 100(5):697-700. PubMed ID: 18378546
[TBL] [Abstract][Full Text] [Related]
12. Comparative analgesic and mental effects of increasing plasma concentrations of dexmedetomidine and alfentanil in humans.
Angst MS; Ramaswamy B; Davies MF; Maze M
Anesthesiology; 2004 Sep; 101(3):744-52. PubMed ID: 15329600
[TBL] [Abstract][Full Text] [Related]
13. Sedative, analgesic, and cardiovascular effects of levomedetomidine alone and in combination with dexmedetomidine in dogs.
Kuusela E; Vainio O; Kaistinen A; Kobylin S; Raekallio M
Am J Vet Res; 2001 Apr; 62(4):616-21. PubMed ID: 11327474
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of dexmedetomidine administered to patients with end-stage renal failure and secondary hyperparathyroidism undergoing general anaesthesia.
Zhong W; Zhang Y; Zhang MZ; Huang XH; Li Y; Li R; Liu QW
J Clin Pharm Ther; 2018 Jun; 43(3):414-421. PubMed ID: 29247451
[TBL] [Abstract][Full Text] [Related]
15. Influence of cardiac output on dexmedetomidine pharmacokinetics.
Dutta S; Lal R; Karol MD; Cohen T; Ebert T
J Pharm Sci; 2000 Apr; 89(4):519-27. PubMed ID: 10737913
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow.
Prielipp RC; Wall MH; Tobin JR; Groban L; Cannon MA; Fahey FH; Gage HD; Stump DA; James RL; Bennett J; Butterworth J
Anesth Analg; 2002 Oct; 95(4):1052-9, table of contents. PubMed ID: 12351293
[TBL] [Abstract][Full Text] [Related]
17. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.
Scheinin H; Aantaa R; Anttila M; Hakola P; Helminen A; Karhuvaara S
Anesthesiology; 1998 Sep; 89(3):574-84. PubMed ID: 9743392
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of dexmedetomidine administered as a constant rate infusion in horses.
Ranheim B; Risberg ÅI; Spadavecchia C; Landsem R; Haga HA
J Vet Pharmacol Ther; 2015 Feb; 38(1):93-6. PubMed ID: 25229603
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients.
Iirola T; Ihmsen H; Laitio R; Kentala E; Aantaa R; Kurvinen JP; Scheinin M; Schwilden H; Schüttler J; Olkkola KT
Br J Anaesth; 2012 Mar; 108(3):460-8. PubMed ID: 22277665
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary effects and pharmacokinetics of i.v. dexmedetomidine in ponies.
Bettschart-Wolfensberger R; Freeman SL; Bowen IM; Aliabadi FS; Weller R; Huhtinen M; Clarke KW
Equine Vet J; 2005 Jan; 37(1):60-4. PubMed ID: 15651736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
